StreetAccount Summary - Trading higher/lower: EU mid-morning
FDA approves Genus's PRRS Resistant Pig gene edit for use in US food supply chain (1586.0000p, 0)
Genus appoints Andy Russell as CFO, effective 1-Aug (1914.0000p, 0)
Genus reports H1 adjusted PBT £35.4M vs FactSet £35.2M and guidance of at least £35M (1830.0000p, 0)
Genus initiated buy at Singer Capital Markets (pre-open) (1856.0000p, -12)
Powered by FactSet Research Systems Inc.